Evotec SE (EVO) NASDAQ

2.95

-0.12(-3.91%)

Updated at June 02 04:00PM

Currency In USD

Key Executives

Name	Title	Pay	Year Born
Christian Wojczewski	CEO & Chairperson of the Management Board	2.91M	1973
Ian Hunneyball	Senior Vice President of Programme Management & Clinical Operations	135,117	1950
Ingrid Mller	Chief Operating Officer & Member of Management Board	673,657	1972
Cord Dohrmann	Chief Scientific Officer & Member of Management Board	888,742	1964
Aurelie Dalbiez	Chief People Officer & Member of Management Board	1.12M	1977
Paul Hitchin	Chief Financial Officer & Member of Management Board	1.34M	1976
Claire Hinshelwood	Chief Financial Officer & Member of Management Board	1.34M	N/A
Uwe Andag	EVP Head of Metabolic Diseases	0	N/A
Christiane Honisch	SVP Head of Diagnostics	0	N/A
David Hallet	Executive Vice President	0	N/A
Claudia Karnbach	Global Head & Executive VP of Partnering Excellence & Operations	0	N/A
Christian Dargel	EVice President Global Head of Legal & Compliance	0	1971
Guy Rachmuth	Senior VP of Global Strategic Business Development & Partnerships	0	N/A
Philip Boehme	Executive Vice President of Partnering & Transformation	0	N/A
Sarah Fakih	Executive VP, Head of Global Communications & Investor Relations	0	N/A
Bernd Mühlenweg	Senior VP & Head of Global Business Development	0	N/A

Name

Title

Pay

Year Born

Christian Wojczewski

CEO & Chairperson of the Management Board

2.91M

1973

Ian Hunneyball

Senior Vice President of Programme Management & Clinical Operations

135,117

1950

Ingrid Mller

Chief Operating Officer & Member of Management Board

673,657

1972

Cord Dohrmann

Chief Scientific Officer & Member of Management Board

888,742

1964

Aurelie Dalbiez

Chief People Officer & Member of Management Board

1.12M

1977

Paul Hitchin

Chief Financial Officer & Member of Management Board

1.34M

1976

Claire Hinshelwood

Chief Financial Officer & Member of Management Board

1.34M

N/A

Uwe Andag

EVP Head of Metabolic Diseases

N/A

Christiane Honisch

SVP Head of Diagnostics

N/A

David Hallet

Executive Vice President

N/A

Claudia Karnbach

Global Head & Executive VP of Partnering Excellence & Operations

N/A

Christian Dargel

EVice President Global Head of Legal & Compliance

1971

Guy Rachmuth

Senior VP of Global Strategic Business Development & Partnerships

N/A

Philip Boehme

Executive Vice President of Partnering & Transformation

N/A

Sarah Fakih

Executive VP, Head of Global Communications & Investor Relations

N/A

Bernd Mühlenweg

Senior VP & Head of Global Business Development

N/A

Description

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.